ACRIN 6684: Multicenter, phase II assessment of tumor hypoxia in newly diagnosed glioblastoma using magnetic resonance spectroscopy

A multi-center imaging trial by the American College of Radiology Imaging Network (ACRIN) “A Multicenter, phase II assessment of tumor hypoxia in glioblastoma using (18)F Fluoromisonidazole (FMISO) with PET and MRI (ACRIN 6684)”, was conducted to assess hypoxia in patients with glioblastoma (GBM). T...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:PLoS One
Main Authors: Ratai, Eva-Maria, Zhang, Zheng, Fink, James, Muzi, Mark, Hanna, Lucy, Greco, Erin, Richards, Todd, Kim, Daniel, Andronesi, Ovidiu C., Mintz, Akiva, Kostakoglu, Lale, Prah, Melissa, Ellingson, Benjamin, Schmainda, Kathleen, Sorensen, Gregory, Barboriak, Daniel, Mankoff, David, Gerstner, Elizabeth R.
Format: Artigo
Sprog:Inglês
Udgivet: Public Library of Science 2018
Fag:
Research Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6002091/
https://ncbi.nlm.nih.gov/pubmed/29902200
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0198548
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker